ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Outcome measures"

  • Abstract Number: 2118 • 2012 ACR/ARHP Annual Meeting

    Validation of Prognostic Biomarkers for RA: Testing of 14-3-3 Eta According to the Omeract Soluble Biomarker Criteria

    Walter P. Maksymowych1, Désirée van der Heijde2, R. Landewe3, George A. Wells4, Joan M. Bathon5, Clifton O. Bingham III6, Vivian P. Bykerk7, Mikkel Ostergaard8, Hilde B. Hammer9, Maarten Boers10, Paul Peter Tak11, Oliver M. FitzGerald12, Christopher T. Ritchlin13, Dafna D. Gladman14, Philip J. Mease15, Dirkjan van Schaardenburg16, Marina Backhaus17, Bernard Combe18, Gianfranco Ferraccioli19 and Anthony Marotta20, 1Department of Medicine, University of Alberta, Edmonton, AB, Canada, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Division of Clinical Immunology and Rheumatology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, 4Epidemiology & Community Med, Univ of Ottawa Faculty of Med, Ottawa, ON, Canada, 5Columbia University, New York, NY, 6Rheumatology, Johns Hopkins University, Baltimore, MD, 7Rheumatology, Hospital for Special Surgery, New York, NY, 8Dept of Rheumatology RM, Copenhagen University Hospital, Glostrup, Denmark, 9Dept of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 10Epidemiology & Biostatistics, VU University Medical Center, Amsterdam, Netherlands, 11Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 12Rheumatology, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland, 13Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, 14Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 15Swedish Rheumatology Research Group, Seattle, WA, 16Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, 17Rheumatology/Immunology, Charite University Hospital, Berlin, Germany, 18Rheumatology, Hopital Lapeyronie, Montpellier, France, 19Division of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy, 20Augurex Life Sciences Corp, North Vancouver, BC, Canada

    Background/Purpose: The OMERACT soluble biomarker sub-committee has published validation criteria related to truth, discrimination and feasibility for biomarkers reflecting structural damage1. The large majority of…
  • Abstract Number: 869 • 2012 ACR/ARHP Annual Meeting

    Concepts Which Determine Health in a Positive Way Are Important to People with Rheumatoid Arthritis and Are Covered by Some Patient-Reported Outcome Instruments

    Mona Dür1, Michaela Coenen2, Josef S. Smolen3 and Tanja A. Stamm4, 1Internal Medicine III Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 2Department of Medical lnformatics, Biometry and Epidemiology, Research Unit for Biopsychosocial Health, Ludwig-Maximilians-University, Munich, Germany, 3Division of Rheumatology, Department of Internal Medicine III,, Medical University of Vienna and Hietzing Hospital, Vienna, Austria, 4Rheumatology, Medical University of Vienna, Vienna, Austria

    Background/Purpose: Rheumatoid arthritis is a chronic autoimmune disease that has a major impact on functioning, health and well-being. Concepts which determine health in a positive…
  • Abstract Number: 2100 • 2012 ACR/ARHP Annual Meeting

    Relative, Reliability-Adjusted Diagnostic Test Accuracy of Erosion Detection Between Magnetic Resonance Imaging and Radiography in Rheumatoid Arthritis

    Ruben Tavares1, Naveen Parasu2, Karen Finlay2, Erik Jurriaans2, Hao Wu1, Karen A. Beattie3, Maggie Larche4, Lawrence E. Hart5, William G. Bensen6, Raja S. Bobba4, Alfred A. Cividino3, Colin E. Webber7, Jean-Eric Tarride8 and Jonathan D. Adachi9, 1McMaster University, Hamilton, ON, Canada, 2Radiology, Hamilton Health Sciences, Hamilton, ON, Canada, 3Medicine, McMaster University, Hamilton, ON, Canada, 4Rheumatology, McMaster University, Hamilton, ON, Canada, 5Medicine (Rheumatology), St. Joseph's Health Care, Hamilton, ON, Canada, 6Department of Medicine, Division of Rheumatology, St. Joseph's Hospital and McMaster University, Hamilton, ON, Canada, 7Department of Nuclear Medicine, Hamilton Health Sciences, Hamilton, ON, Canada, 8Clinical Epidemiology and Biostatistics (CE&B) and Economics, Programs for Assessment of Technology in Health (PATH) Research Institute, Hamilton, ON, Canada, 9St Joseph's Healthcare Hamilton, Hamilton, ON, Canada

    Background/Purpose: In rheumatoid arthritis (RA), erosion detection on radiography (X-ray) compared to magnetic resonance imaging (MRI) is characterized by low sensitivity and high specificity.  This…
  • Abstract Number: 710 • 2012 ACR/ARHP Annual Meeting

    Optical Density Measure of the Papillary Dermis Discriminates As Abnormal Clinically Uninvolved Skin in Systemic Sclerosis and Correlates with Severity of Skin Thickness

    Giuseppina Abignano1, Sibel Z. Aydin2, Concepcion Castillo-Gallego3, Daniel Woods4, Adam Meekings5, Dennis McGonagle6, Paul Emery7 and Francesco Del Galdo8, 1Chapel Allerton Hospital Leeds Insitute of Molecular medicine, Division of Rheumatic and Musculoskeletal Disease, University of Leeds, Leeds Institute of Molecular Medicine and LMBRU, Leeds, United Kingdom, 2Unit of Rheumatology, Medeniyet University, Goztepe Training and Research Hospital, Istanbul, Turkey, 3Rheumatology, Hospital La Paz - IdiPaz, Madrid, Spain, 4Michelson Diagnostics Ltd, Kent, United Kingdom, 5Michelson Diagnostics Ltd, Kent, United Kingdom, Kent, United Kingdom, 6Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 7Division of Rheumatic and Musculoskeletal Disease, University of Leeds, Leeds Institute of Molecular Medicine and LMBRU, Leeds, United Kingdom, 8Musculoskeletal Diseases, University of Leeds, Leeds Institute of Molecular Medicine and LMBRU, Leeds, United Kingdom

    Background/Purpose: Skin involvement in systemic sclerosis (SSc) is often primary outcome in clinical trials and its severity inversely correlates with prognosis. Nevertheless, an objective quantitative…
  • Abstract Number: 2064 • 2012 ACR/ARHP Annual Meeting

    Regular Measure of Disease Activity During the Routine Care of Rheumatoid Arthritis Patients Involves Some Extra Work but Positive Results

    Lissiane K. N. Guedes1, Ana Cristina Medeiros Ribeiro2, Karina Rossi Bonfiglioli3, Diogo Domiciano1, Carolina Reither Vizioli1, Gilmara Franco da Cunha1, Andressa Silva Abreu1, Filipi M. Mello1, Ana Luiza de Aguiar Foelkel4, Celio R. Gonçalves1 and Ieda Laurindo1, 1Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 2Reumatologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, 3Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 4Rheumatology, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: According to treat to target recommendations the use of validated composite measures of disease activity, which include joint assessments, is needed in routine clinical…
  • Abstract Number: 631 • 2012 ACR/ARHP Annual Meeting

    Peripheral Neuropathy Due to Systemic Lupus Erythematosus (SLE) Itself: Incidence, Disease Risk Factors and Outcome

    Simone Fargetti1, Samuel K. Shinjo2, Sandra G. Pasoto1, Ana L. Calich1, Eloisa Bonfa3 and Eduardo F. Borba1, 1Rheumatology Division, University of Sao Paulo, Sao Paulo, Brazil, 2Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, 3Rheumatology Division, University of São Paulo, Sao Paulo, Brazil

    Background/Purpose: Peripheral neuropathy (PN) solely attributable to SLE itself is difficult to define since most of these patients are exposed to several other conditions that…
  • Abstract Number: 2068 • 2012 ACR/ARHP Annual Meeting

    Is There a Difference in Rheumatology Patient Reported Outcomes When Measured At Home Versus the Clinic Setting?

    C.J. Inman1, Frederick Wolfe2 and Kaleb Michaud3, 1Pediatric Administration, University of Utah, Salt Lake City, UT, 2National Data Bank for Rheumatic Diseases, Wichita, KS, 3Rheumatology, National Data Bank for Rheumatic Diseases & University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Registries have become a common tool for collecting patient-centered outcome measures. Clinical effectiveness research may be improved if data from multiple registries could be…
  • Abstract Number: 563 • 2012 ACR/ARHP Annual Meeting

    In Ankylosing Spondylitis, a Decrease in MRI Spinal Inflammation Predicts Improvement in Spinal Mobility Independently of Patient Reported Symptomatic Improvement

    Pedro Machado1, Robert Landewé2, Jürgen Braun3, Xenofon Baraliakos4, Kay-Geert A. Hermann5, Benjamin Hsu6, Daniel Baker7 and Désirée van der Heijde1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Heerlen, Netherlands, 3PsAID taskforce, EULAR, Zurich, Switzerland, 4Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany, 5Radiology, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany, 6Janssen Research & Development, LLC., Spring House, PA, 7Research and Development, Centocor Inc., Malvern/Philadelphia, PA

    Background/Purpose: It has been previously shown that spinal mobility in ankylosing spondylitis (AS) is associated with the level of inflammation of the spine. However an…
  • Abstract Number: 2029 • 2012 ACR/ARHP Annual Meeting

    Reliability of Scoring a Disease Damage Measure for Juvenile Localized Scleroderma

    Kathryn S. Torok1, Suzanne C. Li2, Christina Kelsey3, Mara L Becker4, Fatma Dedeoglu5, Robert C. Fuhlbrigge6, Gloria Higgins7, Sandy D. Hong8, Maria F. Ibarra9, Ronald Laxer10, Thomas G. Mason II11, Marilynn G. Punaro12, Elena Pope13, C. Egla Rabinovich14 and Katie G. Stewart12, 1Pediatric Rheumatology, Scleroderma Center of Pittsburgh, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, 2Pediatrics, Joseph M Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, NJ, 3Pediatric Rheumatology, Univ of Pittsburgh Med Ctr, Pittsburgh, PA, 4Clinical Pharmacology and Rheumatology, Children's Mercy Hospital, Kansas City, MO, 5Division of Immunology, Boston Children's Hospital, Boston, MA, 6Pediatric Rheumatology, Childrens Hospital, Boston, MA, 7Pediatric Rheumatology NATIONWIDE CHILDRENS HOSPITAL, PRCSG-Cincinnati Children's Hospital Medical Center, Columbus, OH, 8Pediatrics-Rheumatology, U of Iowa Children's Hosp, Iowa City, IA, 9Pediatric Rheumatolgy, Children's Mercy Hospital, Kansas City, MO, 10Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 11Rheumatology, Mayo Clinic Rochester, Rochester, MN, 12Pediatric Rheumatology, Texas Scottish Rite Hospital, Dallas, TX, 13Dermatology, The Hospital for Sick Children, Toronto, ON, Canada, 14Pediatric Rheumatology, Duke University Medical Center, Durham, NC

    Background/Purpose: .    In order to more accurately capture disease activity and damage in juvenile Localized Scleroderma (jLS) and to develop an accepted outcome measure for…
  • Abstract Number: 397 • 2012 ACR/ARHP Annual Meeting

    Assessment of Global Disease Activity in Rheumatoid Arthritis Patients Monitored in the Measurement of Efficacy of Treatment in the Era of Rheumatology Database: The patient’s Versus the rheumatologist’s Opinion

    E. Gvozdenovic1, R. Koevoets1, R. Wolterbeek2, Désirée van der Heijde3, T.W.J. Huizinga1, C.F. Allaart1 and Robert B. M. Landewé4, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Biostatistics, Leiden University Medical Center, Leiden, Netherlands, 3Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 4Academic Medical Center/University of Amsterdam & Atrium Medical Center, Amsterdam, Netherlands

    Background/Purpose: Disagreement on disease activity between rheumatoid arthritis (RA) patients and rheumatologists may influence treatment decisions and compliance.  The aim is to compare the physician's…
  • Abstract Number: 2037 • 2012 ACR/ARHP Annual Meeting

    Poor Quality of Gout Care Is Strongly Associated with Higher Gout-Related Health Care Utilization

    Jasvinder A. Singh1 and Joshua Richman2, 1Department of Medicine, University of Alabama, Tuscaloosa, AL, 2Biostatistics, UAB School of Medicine, Birmingham, AL

    Background/Purpose:   Proponents of improving quality of gout care have suggested various gout quality indicators, but no study to date has shown the link between…
  • Abstract Number: 403 • 2012 ACR/ARHP Annual Meeting

    The Impact of Reaching Low Disease Activity in the First Year On Future Disability and Damage in Patients with Early Rheumatoid Arthritis

    Pooneh Akhavan1, George A. Tomlinson2, Paul R. Fortin3 and Claire Bombardier1, 1Rheumatology, University of Toronto, Toronto, ON, Canada, 2Dept of Medicine/Rheumatology, Toronto General Hospital, Toronto, ON, Canada, 3Medicine, Centre de Recherche du Chu de Québec et Université Laval, Quebec City, QC, Canada

    Background/Purpose: Remission has been proposed as the goal of treatment in patients with early rheumatoid arthritis (RA) by current clinical practice guidelines. Remission is ideal…
  • « Previous Page
  • 1
  • …
  • 47
  • 48
  • 49
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology